• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量口服糖皮质激素及同时玻璃体内注射贝伐单抗后引发的难治性硬皮病肾危象。

Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab.

作者信息

Hanna Ramy M, Abdelnour Lama, Zuckerman Jonathan E, Ferrey Antoney J, Pai Alex, Vahabzadeh Kambiz, Wilson James, Torres Everado A, Kalantar-Zadeh Kamyar, Kurtz Ira B

机构信息

Division of Nephrology, Department of Medicine, University of California Irvine, Irvine, CA, USA.

UC Irvine School of Medicine, Orange, CA, USA.

出版信息

SAGE Open Med Case Rep. 2020 Aug 21;8:2050313X20952650. doi: 10.1177/2050313X20952650. eCollection 2020.

DOI:10.1177/2050313X20952650
PMID:32913652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7443985/
Abstract

Scleroderma renal crisis is a serious complication that can develop in certain patients with systemic sclerosis. Some risks have been identified as potential triggers of scleroderma renal crisis, including the high-dose oral corticosteroids. Here, we present a patient who developed clinically severe systemic sclerosis and scleroderma renal crisis after exposure to oral corticosteroids and intravitreal vascular endothelial growth factor blockade with bevacizumab for cotton wool spots. The patient's scleroderma renal crisis was severe, progressive, and refractory to the standard of care therapy: oral captopril. Biopsy showed a diffuse thrombotic microangiopathy and findings consistent with scleroderma renal crisis. We hypothesize that depletion of systemic vascular endothelial growth factor with intravitreal anti-vascular endothelial growth factor injections likely contributed to the particularly severe presentation seen in this case. Though the finding of a monoclonal gammopathy of undetermined significance is another complicating factor, this case suggests that vascular endothelial growth factor inhibition may be a newly recognized trigger of scleroderma renal crisis.

摘要

硬皮病肾危象是一种可在某些系统性硬化症患者中发生的严重并发症。一些风险已被确定为硬皮病肾危象的潜在触发因素,包括大剂量口服糖皮质激素。在此,我们报告一名患者,其在因棉絮斑接受口服糖皮质激素和玻璃体内注射贝伐单抗阻断血管内皮生长因子后,出现了临床严重的系统性硬化症和硬皮病肾危象。该患者的硬皮病肾危象严重、进行性发展且对标准治疗药物口服卡托普利无效。活检显示弥漫性血栓性微血管病,结果符合硬皮病肾危象。我们推测,玻璃体内注射抗血管内皮生长因子导致全身血管内皮生长因子耗竭可能是该病例中所见特别严重表现的原因。尽管意义未明的单克隆丙种球蛋白病这一发现是另一个复杂因素,但该病例提示血管内皮生长因子抑制可能是硬皮病肾危象一个新发现的触发因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/78e51f7de480/10.1177_2050313X20952650-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/61eea872e434/10.1177_2050313X20952650-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/68893edd6e86/10.1177_2050313X20952650-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/49572e26dd02/10.1177_2050313X20952650-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/78e51f7de480/10.1177_2050313X20952650-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/61eea872e434/10.1177_2050313X20952650-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/68893edd6e86/10.1177_2050313X20952650-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/49572e26dd02/10.1177_2050313X20952650-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51c/7443985/78e51f7de480/10.1177_2050313X20952650-fig4.jpg

相似文献

1
Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab.大剂量口服糖皮质激素及同时玻璃体内注射贝伐单抗后引发的难治性硬皮病肾危象。
SAGE Open Med Case Rep. 2020 Aug 21;8:2050313X20952650. doi: 10.1177/2050313X20952650. eCollection 2020.
2
Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.硬皮病相关性肾危象合并血清阴性硬皮病和单克隆丙种球蛋白血症患者的微血管病性溶血性贫血
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221074591. doi: 10.1177/23247096221074591.
3
[Renal involvement in patients with systemic sclerosis].[系统性硬化症患者的肾脏受累情况]
Nephrol Ther. 2011 Jun;7(3):192-9. doi: 10.1016/j.nephro.2011.03.006. Epub 2011 Apr 27.
4
Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis.COVID-19 感染后继发系统性硬化症伴反复皮质激素诱导的硬皮病性肾危象。
BMJ Case Rep. 2023 Mar 17;16(3):e253735. doi: 10.1136/bcr-2022-253735.
5
Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.研究C5抑制疗法在硬皮病肾危象所致血栓性微血管病中的作用——文献综述
Semin Arthritis Rheum. 2023 Dec;63:152256. doi: 10.1016/j.semarthrit.2023.152256. Epub 2023 Aug 22.
6
Scleroderma renal crisis with coexisting segmental arterial mediolysis presenting as intraperitoneal bleeding: a case report.硬皮病肾危象合并节段性动脉中层溶解症表现为腹腔内出血:一例报告
J Med Case Rep. 2019 Mar 20;13(1):74. doi: 10.1186/s13256-019-1993-z.
7
Scleroderma renal crisis triggered by ibuprofen: Insights on complement-directed therapy.布洛芬引发的硬皮病肾危象:补体导向治疗的见解
J Scleroderma Relat Disord. 2023 Oct;8(3):NP6-NP8. doi: 10.1177/23971983231163663. Epub 2023 Apr 4.
8
Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report.他克莫司和泼尼松龙诱发的迟发性硬皮病肾危象:一例报告
Am J Ther. 2014 Sep-Oct;21(5):e130-3. doi: 10.1097/MJT.0b013e3182583ba1.
9
Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury.玻璃体内注射抗血管内皮生长因子抗体可诱导肾小球内皮细胞损伤。
Case Rep Nephrol. 2019 Dec 21;2019:2919080. doi: 10.1155/2019/2919080. eCollection 2019.
10
Eculizumab Use in Scleroderma Renal Crisis With Thrombotic Microangiopathy: A Case Report.依库珠单抗用于治疗伴有血栓性微血管病的硬皮病肾危象:一例报告
Kidney Med. 2023 Nov 27;6(1):100753. doi: 10.1016/j.xkme.2023.100753. eCollection 2024 Jan.

引用本文的文献

1
Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry.玻璃体内血管内皮生长因子抑制剂全身及肾脏毒性登记处。
Clin Kidney J. 2025 Jun 27;18(8):sfaf206. doi: 10.1093/ckj/sfaf206. eCollection 2025 Aug.
2
Thrombotic Microangiopathy and Multiple Organ Failure in Scleroderma Renal Crisis: A Case Report.硬皮病肾危象中的血栓性微血管病与多器官功能衰竭:一例报告
Cureus. 2023 Aug 29;15(8):e44322. doi: 10.7759/cureus.44322. eCollection 2023 Aug.
3
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema.

本文引用的文献

1
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy.糖尿病性增殖性视网膜病变玻璃体腔内注射血管内皮生长因子阻滞剂后蛋白尿和肾功能恶化
Clin Kidney J. 2020 Jun 28;13(6):969-980. doi: 10.1093/ckj/sfaa049. eCollection 2020 Dec.
2
Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab.玻璃体内注射贝伐单抗致糖尿病肾病蛋白尿加重,改用雷珠单抗后病情改善。
SAGE Open Med Case Rep. 2020 Feb 16;8:2050313X20907033. doi: 10.1177/2050313X20907033. eCollection 2020.
3
玻璃体腔注射阿柏西普治疗糖尿病性黄斑水肿致肾性血栓性微血管病和肾病性蛋白尿。
BMC Nephrol. 2022 Oct 29;23(1):348. doi: 10.1186/s12882-022-02986-2.
4
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration.玻璃体内血管内皮生长因子抑制剂毒性的综述及1例年龄相关性黄斑变性患者并发血栓性微血管病的塌陷型局灶节段性肾小球硬化病例报告。
Clin Kidney J. 2021 Mar 23;14(10):2158-2165. doi: 10.1093/ckj/sfab066. eCollection 2021 Oct.
Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade.
玻璃体腔内血管内皮生长因子阻断治疗后塌陷型局灶节段性肾小球硬化的发生
Kidney Int Rep. 2019 Aug 7;4(10):1508-1512. doi: 10.1016/j.ekir.2019.07.019. eCollection 2019 Oct.
4
Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy.一名患有蛋白丢失性肠病患者的非典型溶血尿毒综合征
J Int Med Res. 2019 Aug;47(8):4027-4032. doi: 10.1177/0300060519864808. Epub 2019 Jul 31.
5
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence.血管内皮生长因子抑制剂引起的肾毒性:新证据。
Kidney Int. 2019 Sep;96(3):572-580. doi: 10.1016/j.kint.2019.02.042. Epub 2019 Apr 9.
6
Management of scleroderma renal crisis.硬皮病肾危象的治疗。
Curr Opin Rheumatol. 2019 May;31(3):223-230. doi: 10.1097/BOR.0000000000000604.
7
Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition.非典型溶血尿毒综合征与补体阻断:补体抑制的既定和新兴用途。
Curr Opin Nephrol Hypertens. 2019 May;28(3):278-287. doi: 10.1097/MNH.0000000000000499.
8
Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension.三名接受玻璃体内血管内皮生长因子抑制剂注射治疗的患者,随后出现慢性蛋白尿和高血压加重的情况。
Clin Kidney J. 2019 Feb;12(1):92-100. doi: 10.1093/ckj/sfy060. Epub 2018 Jul 27.
9
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.肾脏意义单克隆丙种球蛋白病的评估:国际肾脏病和单克隆丙种球蛋白病研究小组的共识报告。
Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4.
10
Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab.硬皮病肾危象伴血栓性微血管病初发:1例使用依库珠单抗治疗成功的病例
Case Rep Nephrol. 2018 Oct 23;2018:6051083. doi: 10.1155/2018/6051083. eCollection 2018.